)
Visual
test
Axe Compute
Axe Compute (AGPU) investor relations material
Axe Compute Registration Filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Registration Filing summary20 Nov, 2025
Company overview and business model
Applies artificial intelligence and a proprietary biobank of 150,000+ tumor samples to optimize oncology drug discovery and development, offering services from early discovery to clinical trials.
Operates a digital asset treasury strategy focused on Aethir (ATH) tokens, aiming to create a Strategic Compute Reserve and generate yield through staking and related activities.
PEDAL platform provides early insights for biopharma clients to prioritize oncology portfolios and repurpose failed drug compounds.
Financial performance and metrics
Held approximately 5.6 billion ATH tokens valued at $107 million as of November 19, 2025, with 3.6 billion locked and 2.0 billion unlocked.
Closed a $50.77 million cash private placement in September 2025 and received $173.3 million in discounted value of ATH from a crypto PIPE offering.
Audit reports for 2023 and 2024 include going concern warnings due to recurring losses and accumulated deficit.
Use of proceeds and capital allocation
Proceeds from warrant exercises will be used for the Treasury Strategy, general corporate, and working capital purposes.
Net proceeds from the September offerings are primarily allocated to acquiring ATH tokens and supporting the Treasury Strategy.
How will ATH strategy affect AI drug pipeline funding?
What specific measures address ATH regulatory risks?
How to differentiate POAI from a pure ATH investment?
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Axe Compute
- Q2 2024 saw a $3.2M loss, cost cuts, and new AI/ML partnerships amid going concern risks.AGPU
Q2 20241 Feb 2026 - Registering 1.98M shares for resale; proceeds from warrant exercises fund operations.AGPURegistration Filing16 Dec 2025
- AI-driven oncology firm shifts capital to Aethir tokens, heightening volatility and regulatory risk.AGPURegistration Filing16 Dec 2025
- AI oncology and ATH-focused treasury strategy drive growth amid high digital asset risk.AGPURegistration Filing16 Dec 2025
- Annual meeting to elect directors, ratify KPMG, and approve a new equity incentive plan.AGPUProxy Filing2 Dec 2025
- Proxy covers director elections, auditor, equity plan, warrant issuance, and executive pay votes.AGPUProxy Filing2 Dec 2025
- Shareholders will vote on director elections, auditor ratification, equity plan, and compensation.AGPUProxy Filing2 Dec 2025
- Votes sought for reverse split, $10M equity issuance, and adjournment to maintain Nasdaq listing.AGPUProxy Filing2 Dec 2025
- Vote on reverse split and new equity issuance to maintain Nasdaq listing and financial flexibility.AGPUProxy Filing2 Dec 2025
Next Axe Compute earnings date
Q4 20253 Apr, 2026
Axe Compute
Next Axe Compute earnings date
Q4 20253 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage